Optimi Health Full Year 2024 Earnings: CA$0.067 loss per share (vs CA$0.06 loss in FY 2023)
Optimi Health (CSE:OPTI) Full Year 2024 Results
Key Financial Results
- Net loss: CA$6.04m (loss widened by 16% from FY 2023).
- CA$0.067 loss per share (further deteriorated from CA$0.06 loss in FY 2023).
All figures shown in the chart above are for the trailing 12 month (TTM) period
Optimi Health shares are up 2.3% from a week ago.
Risk Analysis
We don't want to rain on the parade too much, but we did also find 3 warning signs for Optimi Health (2 are a bit unpleasant!) that you need to be mindful of.
New: AI Stock Screener & Alerts
Our new AI Stock Screener scans the market every day to uncover opportunities.
• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies
Or build your own from over 50 metrics.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About CNSX:OPTI
Optimi Health
Engages in the research, cultivation, processing, extraction, and distribution of psilocybin, psilocin, other psychedelic substances, and functional mushrooms for health and wellness markets in Canada and internationally.
Mediocre balance sheet low.